Company Jinan High-tech Development Co., Ltd.

Equities

600807

CNE0000004P2

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 01/07/2024 BST			5-day change	1st Jan Change
2.95 ^CNY	-0.34%		+1.72%	-15.95%

04-26	Jinan High-tech Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-29	China stocks rise as strength in banks offsets developers' falls	RE

Jinan High-tech Development Co Ltd is a China-based company principally engaged in the in vitro diagnostics business. The Company operates three segments. The Real Estate and Property Services Business segment is mainly engaged in real estate development and sales and the provision of property and property leasing services. The In Vitro Diagnostics Business segment is mainly engaged in the research and development, production and sales of products such as molecular diagnostic reagents, molecular diagnostic automated testing equipment, biological sample library management software, biological sample intelligent storage cabinets, biological sample intelligent management terminals, and provides medical testing services. The products are mainly used in the fields of infectious disease prevention and control, pathogenic microorganism detection, food safety testing and other fields. The Other Business segment is mainly engaged in trading business and other businesses.

Number of employees: 731

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostics 51.3 %	497	29.0 %	367	51.3 %	-26.20%
Real Estate and Property Services 17.3 %	-	-	124	17.3 %	-
Trade and Other Business 16.8 %	-	-	120	16.8 %	-
Garden and Municipal Construction 15.3 %	164	9.5 %	109	15.3 %	-33.21%
Inter-segment Eliminations -0.6 %	-59	-3.4 %	-4	-0.6 %	-92.46%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	771	46.6 %	691	100.0 %	-10.39%

Managers	Title	Age	Since
Xue Feng Lei DFI	Director of Finance/CFO	45	16/01/23
Wei Jia BRD	Director/Board Member	44	04/01/21
Yun Guo Zheng BRD	Director/Board Member	44	28/03/19
Wei Wang IRC	Investor Relations Contact	-	-
Ji Hua Yang PRN	Corporate Officer/Principal	45	18/04/19

Members of the board	Title	Age	Since
Xin Zhao BRD	Director/Board Member	41	01/07/22
Ji Hua Yang PRN	Corporate Officer/Principal	45	18/04/19
Wei Zheng BRD	Director/Board Member	51	09/08/22
Yun Guo Zheng BRD	Director/Board Member	44	28/03/19
Xue Li Dong BRD	Director/Board Member	57	28/03/19
De Jun Yue BRD	Director/Board Member	56	28/03/19
Cheng Dong Wang CHM	Chairman	48	28/03/19
Xue Feng Lei DFI	Director of Finance/CFO	45	16/01/23
Wei Jia BRD	Director/Board Member	44	04/01/21
Bao Jian Wu BRD	Director/Board Member	46	26/12/21

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	884,634,731	600,108,884 ( 67.84 %)	0	67.84 %

Name	Equities	%	Valuation
Fullgoal Fund Management Co., Ltd. 0.009858 %	63,500	0.009858 %	26 122 ¥
Harfor Fund Management Co., Ltd. 0.005589 %	36,000	0.005589 %	14 809 ¥
Guotai Asset Management Co., Ltd. 0.000373 %	2,400	0.000373 %	987 ¥

Jinan High-tech Development Co., Ltd.

Main Office Bldg, Longaotian Street No. 1577 Longao North Road

250101, Jinan

http://www.tyanhome.com.cn

address Jinan High-tech Development Co., Ltd.(600807)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
JINAN HIGH-TECH DEVELOPMENT CO., LTD.	-15.95%	360M
BIOMÉRIEUX	-10.83%	11.36B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-19.13%	7.17B
LANTHEUS HOLDINGS, INC.	+27.26%	5.55B
DIASORIN S.P.A.	+3.47%	5.33B
AUTOBIO DIAGNOSTICS CO., LTD.	-20.49%	3.65B
ANDON HEALTH CO., LTD.	+6.88%	2.59B
10X GENOMICS, INC.	-66.61%	2.23B
VITROLIFE AB	-14.18%	2.2B
MYRIAD GENETICS, INC.	+29.31%	2.17B

Diagnostic & Testing Substances